Return on investment (ROI), also called return on invested capital, is the profit a company earns for every dollar of long-term capital from both lenders and shareholders, shown as a percentage. It is net income divided by long-term debt plus shareholder equity, and the table shows both amounts. Because debt is included in the base, ROI does not rise just because a company replaces equity with borrowing, which sets it apart from ROE. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
GYRE THERAPEUTICS, INC. roi for the quarter ending 2014-03-31 was -13.52%, a change of -3.40% year-over-year.
GYRE THERAPEUTICS, INC. roi for the quarter ending 2013-12-31 was 9.78%, a 27.71% increase year-over-year.
GYRE THERAPEUTICS, INC. roi for the quarter ending 2013-09-30 was -33.23%, a change of -32.75% year-over-year.
GYRE THERAPEUTICS, INC. roi for the quarter ending 2013-06-30 was -27.66%, a change of -26.60% year-over-year.
GYRE THERAPEUTICS, INC. roi for fiscal 2013 was 9.78%, a 27.71% increase from fiscal 2012.
GYRE THERAPEUTICS, INC. roi for fiscal 2012 was 7.66%, a change of 12.47% from fiscal 2011.
GYRE THERAPEUTICS, INC. roi for fiscal 2011 was -4.80%, a 141.84% decline from fiscal 2010.
GYRE THERAPEUTICS, INC. roi for fiscal 2010 was 11.48%.